Multaq and Blood count abnormal - a phase IV clinical study of FDA data

Summary:

Blood count abnormal is reported as a side effect among people who take Multaq (dronedarone hydrochloride), especially for people who are female, 60+ old, also take Jakafi, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Blood count abnormal when taking Multaq. It is created by eHealthMe based on reports of 10,572 people who have side effects when taking Multaq from the FDA, and is updated regularly.

What is Multaq?

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.

What is Blood count abnormal?

Blood count abnormal is found to be associated with 867 drugs and 702 conditions by eHealthMe. Check the latest studies of Blood count abnormal.

On Aug, 10, 2026

10,572 people reported to have side effects when taking Multaq.
Among them, 17 people (0.16%) have Blood count abnormal.

Could Multaq cause Blood count abnormal?

Among these 17 people:

What is the gender of people who have Blood count abnormal when taking Multaq? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Blood count abnormal when taking Multaq? *

What are other drugs people take besides Multaq? *

What are other side effects people have besides Blood count abnormal? *

Cough: 10 people, 58.82%
Pain In Extremity: 8 people, 47.06%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 41.18%
Fatigue (feeling of tiredness): 7 people, 41.18%
Feeling Abnormal: 7 people, 41.18%
Haematocrit Decreased: 7 people, 41.18%
Haemoglobin Decreased: 7 people, 41.18%
Weakness: 7 people, 41.18%
Hordeolum (small collection of pus (abscess) on the eyelid): 7 people, 41.18%
Back Pain: 7 people, 41.18%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 10 people, 58.82%
Pain: 2 people, 11.76%
Osteoporosis (bones weak and more likely to break): 2 people, 11.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.76%
Gout (uric acid crystals building up in the body): 2 people, 11.76%
Eye Pruritus (eye itching): 2 people, 11.76%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 11.76%
Dry Eyes (lack of adequate tears): 2 people, 11.76%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
Sleep Disorder: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Multaq and have Blood count abnormal?

- Check whether Blood count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Multaq:

Multaq (11,053 reports)

Browse all side effects of Multaq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood count abnormal:

Blood count abnormal (867 drugs)

Browse all the conditions that are associated with Blood count abnormal:

Blood count abnormal (702 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dronedarone hydrochloride (the active ingredients of Multaq) and Multaq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.